Clinical Trials Browser

Phase 2 × Uveal Melanoma × RO5126766 × Clear all

NCT04720417 2025-07-15

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma

Phase 2 Terminated

13 enrolled 13 charts

Uveal Melanoma